QQQ   418.51 (-1.16%)
AAPL   164.93 (-1.26%)
MSFT   401.43 (-0.70%)
META   487.94 (-2.76%)
GOOGL   154.59 (-0.91%)
AMZN   176.06 (-1.76%)
TSLA   149.62 (-0.21%)
NVDA   818.41 (-3.34%)
AMD   150.06 (-3.24%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.29 (-0.24%)
F   12.11 (+0.41%)
MU   107.65 (-3.82%)
GE   150.59 (-1.54%)
CGC   7.74 (-1.15%)
DIS   111.76 (-0.60%)
AMC   3.08 (+5.48%)
PFE   25.75 (+1.42%)
PYPL   62.02 (-0.13%)
XOM   120.13 (+1.36%)
QQQ   418.51 (-1.16%)
AAPL   164.93 (-1.26%)
MSFT   401.43 (-0.70%)
META   487.94 (-2.76%)
GOOGL   154.59 (-0.91%)
AMZN   176.06 (-1.76%)
TSLA   149.62 (-0.21%)
NVDA   818.41 (-3.34%)
AMD   150.06 (-3.24%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.29 (-0.24%)
F   12.11 (+0.41%)
MU   107.65 (-3.82%)
GE   150.59 (-1.54%)
CGC   7.74 (-1.15%)
DIS   111.76 (-0.60%)
AMC   3.08 (+5.48%)
PFE   25.75 (+1.42%)
PYPL   62.02 (-0.13%)
XOM   120.13 (+1.36%)
QQQ   418.51 (-1.16%)
AAPL   164.93 (-1.26%)
MSFT   401.43 (-0.70%)
META   487.94 (-2.76%)
GOOGL   154.59 (-0.91%)
AMZN   176.06 (-1.76%)
TSLA   149.62 (-0.21%)
NVDA   818.41 (-3.34%)
AMD   150.06 (-3.24%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.29 (-0.24%)
F   12.11 (+0.41%)
MU   107.65 (-3.82%)
GE   150.59 (-1.54%)
CGC   7.74 (-1.15%)
DIS   111.76 (-0.60%)
AMC   3.08 (+5.48%)
PFE   25.75 (+1.42%)
PYPL   62.02 (-0.13%)
XOM   120.13 (+1.36%)
QQQ   418.51 (-1.16%)
AAPL   164.93 (-1.26%)
MSFT   401.43 (-0.70%)
META   487.94 (-2.76%)
GOOGL   154.59 (-0.91%)
AMZN   176.06 (-1.76%)
TSLA   149.62 (-0.21%)
NVDA   818.41 (-3.34%)
AMD   150.06 (-3.24%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.29 (-0.24%)
F   12.11 (+0.41%)
MU   107.65 (-3.82%)
GE   150.59 (-1.54%)
CGC   7.74 (-1.15%)
DIS   111.76 (-0.60%)
AMC   3.08 (+5.48%)
PFE   25.75 (+1.42%)
PYPL   62.02 (-0.13%)
XOM   120.13 (+1.36%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
$0.10
+11.2%
$0.13
$0.06
$0.30
$5.54M0.3415,784 shs475 shs
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
$1.95
$1.61
$2.69
$32.98M0.419,793 shs113,500 shs
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$0.87
+2.8%
$0.92
$0.65
$1.59
$13.86M0.2228,088 shs7,923 shs
Vaso Co. stock logo
VASO
Vaso
$0.30
$0.30
$0.19
$0.37
$55.62M2.03115,298 shs34,926 shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
+9.34%-9.55%-20.40%-29.98%-64.20%
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
0.00%0.00%0.00%0.00%0.00%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-2.39%-5.34%-4.56%-12.35%+9.34%
Vaso Co. stock logo
VASO
Vaso
+1.56%+10.96%-0.17%+1.59%+24.37%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/AN/AN/AN/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
1.2362 of 5 stars
0.04.00.00.00.03.31.9
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/A
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
$100K55.41N/AN/A($0.13) per share-0.77
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
$15.68M0.00N/AN/A$0.53 per share0.00
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$45.78M0.30$0.07 per share12.06$2.93 per share0.30
Vaso Co. stock logo
VASO
Vaso
$81.02M0.69$0.03 per share9.43$0.14 per share2.14

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
-$3.49MN/A0.00N/AN/AN/A-158.84%5/13/2024 (Estimated)
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
-$930K-$0.06N/AN/AN/A-5.93%-12.10%-6.41%N/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$25.13M$1.470.60N/A42.49%-0.33%-0.18%5/20/2024 (Estimated)
Vaso Co. stock logo
VASO
Vaso
$4.80M$0.039.99N/A5.93%19.02%6.59%5/13/2024 (Estimated)

Latest VASO, PEYE, STRR, and GTHP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/22/2024Q4 2023
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.03-$0.02+$0.01-$0.12$9.00 million$14.11 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/AN/A
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/A
0.29
0.16
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
0.23
1.42
0.76
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/A
3.99
3.59
Vaso Co. stock logo
VASO
Vaso
N/A
1.50
1.45

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
9.69%
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.84%
Vaso Co. stock logo
VASO
Vaso
N/A

Insider Ownership

CompanyInsider Ownership
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
66.83%
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
22.70%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
28.83%
Vaso Co. stock logo
VASO
Vaso
44.56%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
455.69 million18.47 millionNot Optionable
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
5016.92 million13.08 millionNot Optionable
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
17115.85 million11.28 millionNot Optionable
Vaso Co. stock logo
VASO
Vaso
272185.63 million102.91 millionNot Optionable

VASO, PEYE, STRR, and GTHP Headlines

SourceHeadline
Vaso (OTCMKTS:VASO) Stock Passes Above 200 Day Moving Average of $0.29Vaso (OTCMKTS:VASO) Stock Passes Above 200 Day Moving Average of $0.29
americanbankingnews.com - April 19 at 3:40 AM
Todo aquello que nos quisieron enseñar las canciones de DisneyTodo aquello que nos quisieron enseñar las canciones de Disney
hercampus.com - April 18 at 10:43 AM
Unity Biotechnology gets grant for senolytic agents for treating age-related eye conditionsUnity Biotechnology gets grant for senolytic agents for treating age-related eye conditions
pharmaceutical-technology.com - April 17 at 1:30 PM
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird bioDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird bio
markets.businessinsider.com - April 16 at 11:07 PM
One bold initiative to recruit Mexican doctors to help bridge language barriers back homeOne bold initiative to recruit Mexican doctors to help bridge language barriers back home
whyy.org - April 15 at 12:04 PM
Interior ministry confirms European Parliament and local government elections for June 9Interior ministry confirms European Parliament and local government elections for June 9
msn.com - April 13 at 1:40 AM
Sun shines on Imbros’ Anzac connection in SydneySun shines on Imbros’ Anzac connection in Sydney
neoskosmos.com - April 12 at 8:40 PM
Short Interest in Vaso Co. (OTCMKTS:VASO) Decreases By 45.9%Short Interest in Vaso Co. (OTCMKTS:VASO) Decreases By 45.9%
americanbankingnews.com - April 11 at 5:30 AM
Vaso Co. (OTCMKTS:VASO) Sees Large Drop in Short InterestVaso Co. (OTCMKTS:VASO) Sees Large Drop in Short Interest
americanbankingnews.com - April 11 at 4:56 AM
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BlueSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
markets.businessinsider.com - April 10 at 8:15 PM
BLUE INVESTOR DEADLINE: bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBLUE INVESTOR DEADLINE: bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
stockhouse.com - April 5 at 8:06 PM
Vaso KotroniVaso Kotroni
avclub.com - April 4 at 1:59 PM
Greek top court orders charges against far-right MPs for deceiving votersGreek top court orders charges against far-right MPs for deceiving voters
msn.com - April 4 at 1:59 PM
COMING IN HOT! KIMPTON MAA-LAI BANGKOKS ICONIC "CHILLI FEST" RETURNS FOR A SECOND YEARCOMING IN HOT! KIMPTON MAA-LAI BANGKOK'S ICONIC "CHILLI FEST" RETURNS FOR A SECOND YEAR
ryt9.com - April 4 at 8:59 AM
Shelf Life: Julia AlvarezShelf Life: Julia Alvarez
msn.com - April 2 at 4:48 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUESHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUE
stockhouse.com - April 2 at 4:48 PM
Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2023Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2023
globenewswire.com - April 1 at 4:05 PM
New therapies in treatment of sickle cell anemiaNew therapies in treatment of sickle cell anemia
msn.com - April 1 at 12:07 PM
6 Recently Approved Cell & Gene Therapies—And Why They Matter6 Recently Approved Cell & Gene Therapies—And Why They Matter
biospace.com - April 1 at 2:06 AM
Tim Tszyu suffers devastating first loss to Sebastian Fundora in Las VegasTim Tszyu suffers devastating first loss to Sebastian Fundora in Las Vegas
theaustralian.com.au - March 31 at 4:05 PM
Tim Tszyu v Sebastian Fundora in Las Vegas: result and latest newsTim Tszyu v Sebastian Fundora in Las Vegas: result and latest news
thechronicle.com.au - March 31 at 12:18 AM
A Performance Art Piece Is Coming to the National Mall for Trans Day of VisibilityA Performance Art Piece Is Coming to the National Mall for Trans Day of Visibility
washingtonian.com - March 30 at 2:17 PM
A Monument to the PastA Monument to the Past
thelancet.com - March 29 at 11:15 PM
Wenda Kay Patrick, Masury, OhioWenda Kay Patrick, Masury, Ohio
wkbn.com - March 29 at 6:14 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Guided Therapeutics logo

Guided Therapeutics

OTCMKTS:GTHP
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Precision Optics logo

Precision Optics

OTCMKTS:PEYE
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
Star Equity logo

Star Equity

NASDAQ:STRR
Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.
Vaso logo

Vaso

OTCMKTS:VASO
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.